Need for Hepatitis A Prevention in Patients with Chronic Liver Disease in the Changing Epidemiological Setting of India

Overview

Journal Hum Vaccin Immunother

Specialty Allergy & Immunology

Date 2020 Nov 25

PMID 33236963

Citations 4

Authors

Bhaskar Raju

Anar Andani

Shafi Kolhapure

Ashish Agrawal

Affiliations

Soon will be listed here.

Abstract

The burden of chronic liver disease (CLD) in India is high, particularly among middle-aged men, with nearly 220,000 deaths due to cirrhosis in 2017. CLD increases the risk of infection, severe disease (e.g. hepatitis A virus or HAV superinfection, acute-on-chronic liver failure, fulminant hepatic failure), and mortality. Hence, various countries recommend HAV vaccination for CLD patients. While historic Indian studies showed high seroprevalences of protective HAV antibodies among Indian adults with CLD, the most recent ones found that nearly 7% of CLD patients were susceptible to HAV infection. Studies in healthy individuals have shown that HAV infection in childhood is decreasing in India, resulting in an increasing population of adults susceptible to HAV infection. As patients with CLD are at increased risk of severe HAV infection, now may be the time to recommend HAV vaccination among people with CLD in India.

Citing Articles

Expert consensus and recommendations on the live attenuated hepatitis A vaccine and immunization practices in India.

Shah N, Faridi M, Bhave S, Ghosh A, Balasubramanian S, Arankalle V Hum Vaccin Immunother. 2025; 21(1):2447643.

PMID: 39819191 PMC: 11740680. DOI: 10.1080/21645515.2024.2447643.

Severe acute hepatitis due to hepatitis A virus in adults: Further evidence and a clarion call.

Roy A, Kulkarni A, Goenka M Indian J Gastroenterol. 2024; .

PMID: 39245694 DOI: 10.1007/s12664-024-01655-6.

Vaccination in Patients with Liver Cirrhosis: A Neglected Topic.

Stroffolini T, Stroffolini G Vaccines (Basel). 2024; 12(7).

PMID: 39066353 PMC: 11281357. DOI: 10.3390/vaccines12070715.

Vaccination in Chronic Liver Disease: An Update.

Alukal J, Naqvi H, Thuluvath P J Clin Exp Hepatol. 2022; 12(3):937-947.

PMID: 34975241 PMC: 8710401. DOI: 10.1016/j.jceh.2021.12.003.

A Modern Perspective on Vaccinating Healthcare Service Providers in India: A Narrative Review.

Surendranath M, Wankhedkar R, Lele J, Cintra O, Kolhapure S, Agrawal A Infect Dis Ther. 2021; 11(1):81-99.

PMID: 34773563 PMC: 8590119. DOI: 10.1007/s40121-021-00558-9.

References

Duseja A, Najmy S, Sachdev S, Pal A, Sharma R, Marwah N . High prevalence of non-alcoholic fatty liver disease among healthy male blood donors of urban India. JGH Open. 2019; 3(2):133-139. PMC: 6487825. DOI: 10.1002/jgh3.12117. View

Kumar S, Ratho R, Chawla Y, Chakraborti A . The incidence of sporadic viral hepatitis in North India: a preliminary study. Hepatobiliary Pancreat Dis Int. 2007; 6(6):596-9. View

Dhotial A, Kapoor D, Kumar N . Seroprevalence of hepatitis A virus antibody in patients with chronic liver disease--experience from a tertiary care hospital in north India. Trop Gastroenterol. 2003; 23(4):170-1. View

Verma R, Khanna P . Hepatitis A vaccine should receive priority in National Immunization Schedule in India. Hum Vaccin Immunother. 2012; 8(8):1132-4. PMC: 3551887. DOI: 10.4161/hv.20475. View

Fiuza C, Salcedo M, Clemente G, Tellado J . In vivo neutrophil dysfunction in cirrhotic patients with advanced liver disease. J Infect Dis. 2000; 182(2):526-33. DOI: 10.1086/315742. View

Saraswat V, Singh S, Duseja A, Shukla A, Eapen C, Kumar D . Acute-on-chronic liver failure in India: The Indian National Association for Study of the Liver consortium experience. J Gastroenterol Hepatol. 2016; 31(10):1742-1749. DOI: 10.1111/jgh.13340. View

Acharya S, Batra Y, Bhatkal B, Ojha B, Kaur K, Hazari S . Seroepidemiology of hepatitis A virus infection among school children in Delhi and north Indian patients with chronic liver disease: implications for HAV vaccination. J Gastroenterol Hepatol. 2003; 18(7):822-7. DOI: 10.1046/j.1440-1746.2003.03051.x. View

Lefilliatre P, Villeneuve J . Fulminant hepatitis A in patients with chronic liver disease. Can J Public Health. 2000; 91(3):168-70. PMC: 6980216. View

Choudhuri G, Chaudhari S, Pawar D, Roy D . Etiological Patterns, Liver Fibrosis Stages and Prescribing Patterns of Hepato-Protective Agents in Indian Patients with Chronic Liver Disease. J Assoc Physicians India. 2019; 66(12):58-63. View

10.

Kulkarni S, Sharma M, Rao P, Gupta R, Reddy D . Acute on Chronic Liver Failure-In-Hospital Predictors of Mortality in ICU. J Clin Exp Hepatol. 2018; 8(2):144-155. PMC: 5992306. DOI: 10.1016/j.jceh.2017.11.008. View

11.

Arankalle V, Chadha M, Chitambar S, Walimbe A, Chobe L, Gandhe S . Changing epidemiology of hepatitis A and hepatitis E in urban and rural India (1982-98). J Viral Hepat. 2001; 8(4):293-303. DOI: 10.1046/j.1365-2893.2001.00279.x. View

12.

John A, Chatni S, Narayanan V, Balakrishnan V, Nair P . Seroprevalence of hepatitis A virus in patients with chronic liver disease from Kerala: impact on vaccination policy. J Indian Med Assoc. 2010; 107(12):859-61. View

13.

Joshi N, Rao S, Kumar A, Patil S, Rani S . Hepatitis A vaccination in chronic liver disease: is it really required in a tropical country like India?. Indian J Med Microbiol. 2007; 25(2):137-9. DOI: 10.4103/0255-0857.32720. View

14.

Schweitzer A, Horn J, Mikolajczyk R, Krause G, Ott J . Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013. Lancet. 2015; 386(10003):1546-55. DOI: 10.1016/S0140-6736(15)61412-X. View

15.

. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018; 392(10159):1736-1788. PMC: 6227606. DOI: 10.1016/S0140-6736(18)32203-7. View

16.

Aggarwal R, Goel A . Hepatitis A: epidemiology in resource-poor countries. Curr Opin Infect Dis. 2015; 28(5):488-96. DOI: 10.1097/QCO.0000000000000188. View

17.

Duseja A, Sharma S, Das K, Dhiman R, Chawla Y . Is vaccination against hepatitis A virus required in patients with cirrhosis of the liver?. Trop Gastroenterol. 2005; 25(4):162-3. View

18.

Gadgil P, Fadnis R, Joshi M, Rao P, Chitambar S . Seroepidemiology of hepatitis A in voluntary blood donors from Pune, western India (2002 and 2004-2005). Epidemiol Infect. 2007; 136(3):406-9. PMC: 2870818. DOI: 10.1017/S0950268807008643. View

19.

Sarin S, Choudhury A, Sharma M, Maiwall R, Al Mahtab M, Rahman S . Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific association for the study of the liver (APASL): an update. Hepatol Int. 2019; 13(4):353-390. PMC: 6728300. DOI: 10.1007/s12072-019-09946-3. View

20.

Goel A, Seguy N, Aggarwal R . Burden of hepatitis C virus infection in India: A systematic review and meta-analysis. J Gastroenterol Hepatol. 2018; 34(2):321-329. DOI: 10.1111/jgh.14466. View